| 2028년 3월 19일 2026년 3월 20일 제출 | Ehrlichman Matt Director · Officer: CEO, CHAIRMAN AND FOUNDER · 10% owner | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | 취득(A) | 1,748,472 | 0 | — | 15,462,200 | 직접(D) | 아니요 | F1, F2, F3 - F1 Represents shares of the Issuer's Common Stock earned under a performance-based restricted stock unit (PRSU) award granted on April 7, 2023, following the Compensation Committee's certification of performance achievement on March 19, 2026. The PRSU award was subject to three distinct performance goals of share price, revenue, and Adjusted EBITDA. The earned shares remain subject to a service-based vesting condition through April 7, 2026. The Issuer has confirmed its intent to settle vested shares of Common Stock in numerous transactions over approximately 45 days, between April 7, 2026 and May 21, 2026, to reduce market impact. In addition, the Issuer has adopted a sell-to-cover method (shares will be sold by the Issuer at its election, and without any discretion by the Reporting Person) as the sole means for plan participants to satisfy tax withholding obligations upon the vesting and settlement of awards.
- F2 Represents PRSUs earned due to the achievement of revenue and Adjusted EBITDA goals.
- F3 Each PRSU represented a contingent right to receive, upon achievement of the applicable performance metric and subject to vesting, one share of the Issuer's Common Stock.
| 제출 문서 열기 0001515184-26-000002 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 11월 13일 2026년 11월 17일 제출 | Neagle Matthew Officer: Chief Operating Officer | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 56,250 | 20.9859 | 1,180,456.875 산출: 주식 수 × 주당 가격. 정확한 값 1180456.8750. | 1,680,506 | 직접(D) | 예 | F1, F2 - F1 Represents a sale pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on June 15, 2026 (the 10b5-1 Plan). The 10b5-1 Plan is scheduled to terminate on June 15, 2027 and covers the sale of up to an aggregate of 500,000 shares of the Issuer's common stock. Trading under the 10b5-1 Plan did not commence until at least 90 days following the date on which the plan was entered.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.70 to $21.23 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001837336-26-000054 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 11월 9일 2026년 11월 10일 제출 | Ehrlichman Matt Director · Officer: CEO, CHAIRMAN AND FOUNDER · 10% owner | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 109,043 | 20.1531 | 2,197,554.4833 산출: 주식 수 × 주당 가격. 정확한 값 2197554.4833. | 15,316,747 | 직접(D) | 예 | F1, F2, F3 - F1 The sale represented on this Form 4 was effected pursuant to a previously disclosed Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2025 (the Trading Plan) for personal tax planning purposes and to satisfy tax obligations. The Trading Plan covers the sale of up to an aggregate of 584,998 shares of the Issuer's common stock. All terms of the Trading Plan, including the number of shares to be sold and the minimum sale prices, were fixed at adoption. As of the date of this filing, the Reporting Person has no other Rule 10b5-1 trading plan in effect.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.51 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3 With the sale reported on this Form 4, all shares covered by the Trading Plan have been sold, and the Trading Plan has terminated in accordance with its terms. Following the reported transaction, the Reporting Person continues to beneficially own 21,057,053 shares of the Issuer's common stock, including 6,416,712 shares held by West Equities, LLC, representing approximately 18.4% of the Issuer's outstanding common stock. This amount excludes 676,406 restricted stock units that are scheduled to vest more than 60 days following the date of this Form 4 and therefore are not included in the Reporting Person's beneficial ownership.
| 제출 문서 열기 0001515184-26-000047 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 11월 6일 2026년 11월 6일 제출 | Ehrlichman Matt Director · Officer: CEO, CHAIRMAN AND FOUNDER · 10% owner | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 19,452 | 20.1668 | 392,284.5936 산출: 주식 수 × 주당 가격. 정확한 값 392284.5936. | 15,425,790 | 직접(D) | 예 | F1, F5, F6 - F1 The sales represented on this Form 4 were effected pursuant to a previously disclosed Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2025 (the Trading Plan) for personal tax planning purposes and to satisfy tax obligations. The Trading Plan covers the sale of up to an aggregate of 584,998 shares of the Issuer's common stock. All terms of the Trading Plan, including the number of shares to be sold and the minimum sale prices, were fixed at adoption. As of the date of this filing, the Reporting Person has no other Rule 10b5-1 trading plan in effect.
- F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.43 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6 Following the reported transactions, the Reporting Person beneficially owns 21,166,096 shares of the Issuer's common stock, including 6,416,712 shares held by West Equities, LLC, representing approximately 18.5% of the Issuer's outstanding common stock. This amount excludes 676,406 restricted stock units that are scheduled to vest more than 60 days following the date of this Form 4 and therefore are not included in the Reporting Person's beneficial ownership.
| 제출 문서 열기 0001515184-26-000045 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 11월 5일 2026년 11월 6일 제출 | Ehrlichman Matt Director · Officer: CEO, CHAIRMAN AND FOUNDER · 10% owner | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 5,701 | 21.0905 | 120,236.9405 산출: 주식 수 × 주당 가격. 정확한 값 120236.9405. | 15,634,304 | 직접(D) | 예 | F1, F3 - F1 The sales represented on this Form 4 were effected pursuant to a previously disclosed Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2025 (the Trading Plan) for personal tax planning purposes and to satisfy tax obligations. The Trading Plan covers the sale of up to an aggregate of 584,998 shares of the Issuer's common stock. All terms of the Trading Plan, including the number of shares to be sold and the minimum sale prices, were fixed at adoption. As of the date of this filing, the Reporting Person has no other Rule 10b5-1 trading plan in effect.
- F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.26 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001515184-26-000045 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 11월 5일 2026년 11월 6일 제출 | Ehrlichman Matt Director · Officer: CEO, CHAIRMAN AND FOUNDER · 10% owner | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 189,062 | 20.3788 | 3,852,856.6856 산출: 주식 수 × 주당 가격. 정확한 값 3852856.6856. | 15,445,242 | 직접(D) | 예 | F1, F4 - F1 The sales represented on this Form 4 were effected pursuant to a previously disclosed Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2025 (the Trading Plan) for personal tax planning purposes and to satisfy tax obligations. The Trading Plan covers the sale of up to an aggregate of 584,998 shares of the Issuer's common stock. All terms of the Trading Plan, including the number of shares to be sold and the minimum sale prices, were fixed at adoption. As of the date of this filing, the Reporting Person has no other Rule 10b5-1 trading plan in effect.
- F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.98 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001515184-26-000045 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 11월 4일 2026년 11월 6일 제출 | Ehrlichman Matt Director · Officer: CEO, CHAIRMAN AND FOUNDER · 10% owner | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 251,740 | 21.5758 | 5,431,491.892 산출: 주식 수 × 주당 가격. 정확한 값 5431491.8920. | 15,640,005 | 직접(D) | 예 | F1, F2 - F1 The sales represented on this Form 4 were effected pursuant to a previously disclosed Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2025 (the Trading Plan) for personal tax planning purposes and to satisfy tax obligations. The Trading Plan covers the sale of up to an aggregate of 584,998 shares of the Issuer's common stock. All terms of the Trading Plan, including the number of shares to be sold and the minimum sale prices, were fixed at adoption. As of the date of this filing, the Reporting Person has no other Rule 10b5-1 trading plan in effect.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.05 to $21.93 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001515184-26-000045 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 11월 3일 2026년 11월 5일 제출 | Ehrlichman Matt Director · Officer: CEO, CHAIRMAN AND FOUNDER · 10% owner | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 10,000 | 21.5124 | 215,124 산출: 주식 수 × 주당 가격. 정확한 값 215124.0000. | 15,891,745 | 직접(D) | 예 | F1, F2 - F1 The sale represented on this Form 4 was effected pursuant to a previously disclosed Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2025 (the Trading Plan) for personal tax planning purposes and to satisfy tax obligations. The Trading Plan covers the sale of up to an aggregate of 584,998 shares of the Issuer's common stock. All terms of the Trading Plan, including the number of shares to be sold and the minimum sale prices, were fixed at adoption. This is the Reporting Person's first open-market sale of the Issuer's common stock outside of required sales upon the vesting of equity awards under the Issuer's mandated sell-to-cover program. As of the date of this filing, the Reporting Person has no other Rule 10b5-1 trading plan in effect.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.50 to $21.54 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001515184-26-000043 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 11월 3일 2026년 11월 5일 제출 | Pickerill Alan R Director | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Common Stock | 취득(A) | 5,000 | 1.77 | 8,850 산출: 주식 수 × 주당 가격. 정확한 값 8850.00. | 203,356 | 직접(D) | 아니요 | — | 제출 문서 열기 0001716426-26-000004 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 11월 3일 2026년 11월 5일 제출 | Pickerill Alan R Director | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 5,000 | 21 | 105,000 산출: 주식 수 × 주당 가격. 정확한 값 105000. | 198,356 | 직접(D) | 아니요 | — | 제출 문서 열기 0001716426-26-000004 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 11월 3일 2026년 11월 5일 제출 | Pickerill Alan R Director | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 5,000 | 21 | 105,000 산출: 주식 수 × 주당 가격. 정확한 값 105000. | 193,356 | 직접(D) | 아니요 | — | 제출 문서 열기 0001716426-26-000004 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 11월 3일 2026년 11월 5일 제출 | Pickerill Alan R Director | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 파생증권: Stock Option (right to buy) — 기초자산 Common Stock (5,000) — 행사가 1.77 | 처분(D) | 5,000 | 0 | — | 9,092 | 직접(D) | 아니요 | F1 - F1 The stock options vested quarterly in twelve equal installments from the Vesting Commencement Date, September 20, 2019.
| 제출 문서 열기 0001716426-26-000004 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 11월 2일 2026년 11월 4일 제출 | Neagle Matthew Officer: Chief Operating Officer | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 39,347 | 20.7068 | 814,750.4596 산출: 주식 수 × 주당 가격. 정확한 값 814750.4596. | 1,753,659 | 직접(D) | 예 | F1, F2 - F1 Represents a sale pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on June 15, 2026 (the 10b5-1 Plan). The 10b5-1 Plan is scheduled to terminate on June 15, 2027 and covers the sale of up to an aggregate of 500,000 shares of the Issuer's common stock. Trading under the 10b5-1 Plan did not commence until at least 90 days following the date on which the plan was entered.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.18 to $21.17 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001837336-26-000052 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 11월 2일 2026년 11월 4일 제출 | Neagle Matthew Officer: Chief Operating Officer | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 16,903 | 21.2854 | 359,787.1162 산출: 주식 수 × 주당 가격. 정확한 값 359787.1162. | 1,736,756 | 직접(D) | 예 | F1, F3 - F1 Represents a sale pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on June 15, 2026 (the 10b5-1 Plan). The 10b5-1 Plan is scheduled to terminate on June 15, 2027 and covers the sale of up to an aggregate of 500,000 shares of the Issuer's common stock. Trading under the 10b5-1 Plan did not commence until at least 90 days following the date on which the plan was entered.
- F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.18 to $21.48 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001837336-26-000052 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 10월 30일 2026년 10월 30일 제출 | Kell Sean Davis Director | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 10,284 | 20.3025 | 208,790.91 산출: 주식 수 × 주당 가격. 정확한 값 208790.9100. | 292,863 | 직접(D) | 예 | F1, F2 - F1 Represents a sale pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on August 25, 2025 (the 10b5-1 Plan). The 10b5-1 Plan is scheduled to terminate on January 3, 2027, and covers the sale of up to an aggregate of 20,784 shares of the Issuer's common stock to help satisfy tax obligations upon the vesting of shares received for service on the Company's board of directors. With the sales reported on this Form 4, all shares of the Issuer's common stock subject to the 10b5-1 Plan have been sold, and the 10b5-1 Plan has terminated in accordance with its terms. Trading under the 10b5-1 Plan did not commence until at least 90 days following the date on which the plan was entered.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.50 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001916515-26-000004 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 10월 29일 2026년 10월 30일 제출 | Tabak Shawn Officer: CHIEF FINANCIAL OFFICER | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 30,000 | 21.0246 | 630,738 산출: 주식 수 × 주당 가격. 정확한 값 630738.0000. | 176,059 | 직접(D) | 예 | F1, F2 - F1 Represents a sale pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on November 19, 2025 (the 10b5-1 Plan). The 10b5-1 Plan is scheduled to terminate on March 31, 2027, and covers the sale of up to an aggregate of 140,000 shares of the Issuer's common stock. The remaining shares covered by the 10b5-1 plan are at a limit price that exceeds the most recent Nasdaq closing price. Trading under the 10b5-1 Plan did not commence until at least 90 days following the date on which the plan was entered. This sale was effected in connection with tax planning, and the proceeds from the transaction are being used to help satisfy tax obligations of the Reporting Person
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.14 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001954327-26-000053 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 10월 29일 2026년 10월 30일 제출 | Kell Sean Davis Director | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 10,500 | 20 | 210,000 산출: 주식 수 × 주당 가격. 정확한 값 210000. | 303,147 | 직접(D) | 예 | F1 - F1 Represents a sale pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on August 25, 2025 (the 10b5-1 Plan). The 10b5-1 Plan is scheduled to terminate on January 3, 2027, and covers the sale of up to an aggregate of 20,784 shares of the Issuer's common stock to help satisfy tax obligations upon the vesting of shares received for service on the Company's board of directors. With the sales reported on this Form 4, all shares of the Issuer's common stock subject to the 10b5-1 Plan have been sold, and the 10b5-1 Plan has terminated in accordance with its terms. Trading under the 10b5-1 Plan did not commence until at least 90 days following the date on which the plan was entered.
| 제출 문서 열기 0001916515-26-000004 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 10월 20일 2026년 10월 22일 제출 | Neagle Matthew Officer: Chief Operating Officer | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 31,250 | 18.0149 | 562,965.625 산출: 주식 수 × 주당 가격. 정확한 값 562965.6250. | 1,793,006 | 직접(D) | 예 | F1, F2 - F1 Represents a sale pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on June 15, 2026 (the 10b5-1 Plan). The 10b5-1 Plan is scheduled to terminate on June 15, 2027 and covers the sale of up to an aggregate of 500,000 shares of the Issuer's common stock. Trading under the 10b5-1 Plan did not commence until at least 90 days following the date on which the plan was entered.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.10 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001837336-26-000050 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 10월 20일 2026년 10월 22일 제출 | Reierson Amanda L Director | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 7,418 | 17.9835 | 133,401.603 산출: 주식 수 × 주당 가격. 정확한 값 133401.6030. | 113,261 | 직접(D) | 예 | F1, F2 - F1 Represents a sale pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on June 15, 2026 (the 10b5-1 Plan). The 10b5-1 Plan is scheduled to terminate on June 18, 2027, and covers the sale of up to an aggregate of 54,054 shares of the Issuer's common stock to help satisfy tax obligations upon the vesting of shares received for service on the Company's board of directors. Trading under the 10b5-1 Plan did not commence until at least 90 days following the date on which the plan was entered.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.95 to $18.01 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001950180-26-000010 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 10월 16일 2026년 10월 20일 제출 | Reierson Amanda L Director | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 5,000 | 17.9522 | 89,761 산출: 주식 수 × 주당 가격. 정확한 값 89761.0000. | 120,679 | 직접(D) | 예 | F1, F2 - F1 Represents a sale pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on June 15, 2026 (the 10b5-1 Plan). The 10b5-1 Plan is scheduled to terminate on June 18, 2027, and covers the sale of up to an aggregate of 54,054 shares of the Issuer's common stock to help satisfy tax obligations upon the vesting of shares received for service on the Company's board of directors. Trading under the 10b5-1 Plan did not commence until at least 90 days following the date on which the plan was entered.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.95 to $17.98 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001950180-26-000008 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 10월 16일 2026년 10월 20일 제출 | Neagle Matthew Officer: Chief Operating Officer | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 40,625 | 17.5564 | 713,228.75 산출: 주식 수 × 주당 가격. 정확한 값 713228.7500. | 1,824,256 | 직접(D) | 예 | F1, F2 - F1 Represents a sale pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on June 15, 2026 (the 10b5-1 Plan). The 10b5-1 Plan is scheduled to terminate on June 15, 2027 and covers the sale of up to an aggregate of 500,000 shares of the Issuer's common stock. Trading under the 10b5-1 Plan did not commence until at least 90 days following the date on which the plan was entered.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.12 to $17.98 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001837336-26-000048 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 10월 6일 2026년 10월 7일 제출 | Reierson Amanda L Director | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 8,501 | 17.9529 | 152,617.6029 산출: 주식 수 × 주당 가격. 정확한 값 152617.6029. | 125,679 | 직접(D) | 예 | F1, F2 - F1 Represents a sale pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on June 15, 2026 (the 10b5-1 Plan). The 10b5-1 Plan is scheduled to terminate on June 18, 2027, and covers the sale of up to an aggregate of 54,054 shares of the Issuer's common stock to help satisfy tax obligations upon the vesting of shares received for service on the Company's board of directors. Trading under the 10b5-1 Plan did not commence until at least 90 days following the date on which the plan was entered.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.95 to $17.96 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001950180-26-000006 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 10월 6일 2026년 10월 7일 제출 | Tabak Shawn Officer: CHIEF FINANCIAL OFFICER | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 2,644 | 17.35 | 45,873.4 산출: 주식 수 × 주당 가격. 정확한 값 45873.40. | 210,105 | 직접(D) | 아니요 | F3 - F3 This sale was required by the Issuer at its election (without any discretion by the Reporting Person), and represents shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs that vested on October 5, 2026 on the semi-annual vesting of the Reporting Person's April 7, 2023 RSU grant. The Issuer has adopted this sell-to-cover method as the sole means for plan participants to satisfy tax withholding obligations in connection with the settlement of awards. The RSUs will continue to vest ratably every 6 months over the remaining 48-month vesting period which commenced on April 5, 2024, subject to the Reporting Person's continuous employment or service with the Issuer.
| 제출 문서 열기 0001954327-26-000051 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 10월 6일 2026년 10월 7일 제출 | Tabak Shawn Officer: CHIEF FINANCIAL OFFICER | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 4,046 | 17.35 | 70,198.1 산출: 주식 수 × 주당 가격. 정확한 값 70198.10. | 206,059 | 직접(D) | 아니요 | F4 - F4 This sale was required by the Issuer at its election (without any discretion by the Reporting Person), and represents shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs that vested on October 5, 2026 on the semi-annual vesting of the Reporting Person's April 5, 2024 RSU grant. The Issuer has adopted this sell-to-cover method as the sole means for plan participants to satisfy tax withholding obligations in connection with the settlement of awards. The RSUs will continue to vest ratably every 6 months over the remaining 48-month vesting period which commenced on April 5, 2025, subject to the Reporting Person's continuous employment or service with the Issuer.
| 제출 문서 열기 0001954327-26-000051 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 10월 6일 2026년 10월 7일 제출 | Ehrlichman Matt Director · Officer: CEO, CHAIRMAN AND FOUNDER · 10% owner | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 26,135 | 17.35 | 453,442.25 산출: 주식 수 × 주당 가격. 정확한 값 453442.25. | 15,930,999 | 직접(D) | 아니요 | F3 - F3 This sale was required by the Issuer at its election (without any discretion by the Reporting Person), and represents shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs that vested on October 5, 2026 on the semi-annual vesting of the Reporting Person's April 5, 2024 RSU grant. The Issuer has adopted this sell-to-cover method as the sole means for plan participants to satisfy tax withholding obligations in connection with the settlement of awards. The RSUs will continue to vest ratably every 6 months over the remaining 48-month vesting period which commenced on April 5, 2025, subject to the Reporting Person's continuous employment or service with the Issuer.
| 제출 문서 열기 0001515184-26-000041 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 10월 6일 2026년 10월 7일 제출 | Neagle Matthew Officer: Chief Operating Officer | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 15,153 | 17.35 | 262,904.55 산출: 주식 수 × 주당 가격. 정확한 값 262904.55. | 1,877,609 | 직접(D) | 아니요 | F3 - F3 This sale was required by the Issuer at its election (without any discretion by the Reporting Person), and represents shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs that vested on October 5, 2026 on the semi-annual vesting of the Reporting Person's April 7, 2023 RSU grant. The Issuer has adopted this sell-to-cover method as the sole means for plan participants to satisfy tax withholding obligations in connection with the settlement of awards. The RSUs will continue to vest ratably every 6 months over the remaining 48-month vesting period which commenced on April 5, 2024, subject to the Reporting Person's continuous employment or service with the Issuer.
| 제출 문서 열기 0001837336-26-000046 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 10월 6일 2026년 10월 7일 제출 | Neagle Matthew Officer: Chief Operating Officer | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 12,728 | 17.35 | 220,830.8 산출: 주식 수 × 주당 가격. 정확한 값 220830.80. | 1,864,881 | 직접(D) | 아니요 | F4 - F4 This sale was required by the Issuer at its election (without any discretion by the Reporting Person), and represents shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs that vested on October 5, 2026 on the semi-annual vesting of the Reporting Person's April 5, 2024 RSU grant. The Issuer has adopted this sell-to-cover method as the sole means for plan participants to satisfy tax withholding obligations in connection with the settlement of awards. The RSUs will continue to vest ratably every 6 months over the remaining 48-month vesting period which commenced on April 5, 2025, subject to the Reporting Person's continuous employment or service with the Issuer.
| 제출 문서 열기 0001837336-26-000046 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 10월 5일 2026년 10월 7일 제출 | Tabak Shawn Officer: CHIEF FINANCIAL OFFICER | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 2,746 | 16.8334 | 46,224.5164 산출: 주식 수 × 주당 가격. 정확한 값 46224.5164. | 212,749 | 직접(D) | 아니요 | F1, F2 - F1 This sale was required by the Issuer at its election (without any discretion by the Reporting Person), and represents shares sold to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units (RSUs) that vested on October 4, 2026 on the semi-annual vesting of the Reporting Person's April 4, 2025 RSU grant. The Issuer has adopted this sell-to-cover method as the sole means for plan participants to satisfy tax withholding obligations in connection with the settlement of awards. The RSUs will continue to vest ratably every 6 months over the remaining 48-month vesting period which commenced on April 4, 2026, subject to the Reporting Person's continuous employment or service with the Issuer.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.83 to $16.9701 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001954327-26-000051 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 10월 5일 2026년 10월 7일 제출 | Ehrlichman Matt Director · Officer: CEO, CHAIRMAN AND FOUNDER · 10% owner | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 14,946 | 16.8398 | 251,687.6508 산출: 주식 수 × 주당 가격. 정확한 값 251687.6508. | 15,957,134 | 직접(D) | 아니요 | F1, F2 - F1 This sale was required by the Issuer at its election (without any discretion by the Reporting Person), and represents shares sold to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units (RSUs) that vested on October 4, 2026 on the semi-annual vesting of the Reporting Person's April 4, 2025 RSU grant. The Issuer has adopted this sell-to-cover method as the sole means for plan participants to satisfy tax withholding obligations in connection with the settlement of awards. The RSUs will continue to vest ratably every 6 months over the remaining 48-month vesting period which commenced on April 4, 2026, subject to the Reporting Person's continuous employment or service with the Issuer.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.83 to $17.2713 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001515184-26-000041 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 10월 5일 2026년 10월 7일 제출 | Neagle Matthew Officer: Chief Operating Officer | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 7,318 | 16.834 | 123,191.212 산출: 주식 수 × 주당 가격. 정확한 값 123191.212. | 1,892,762 | 직접(D) | 아니요 | F1, F2 - F1 This sale was required by the Issuer at its election (without any discretion by the Reporting Person), and represents shares sold to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units (RSUs) that vested on October 4, 2026 on the semi-annual vesting of the Reporting Person's April 4, 2025 RSU grant. The Issuer has adopted this sell-to-cover method as the sole means for plan participants to satisfy tax withholding obligations in connection with the settlement of awards. The RSUs will continue to vest ratably every 6 months over the remaining 48-month vesting period which commenced on April 4, 2026, subject to the Reporting Person's continuous employment or service with the Issuer.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.83 to $16.9957 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001837336-26-000046 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 10월 1일 2026년 10월 5일 제출 | Neagle Matthew Officer: Chief Operating Officer | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 35,031 | 16.6137 | 581,994.5247 산출: 주식 수 × 주당 가격. 정확한 값 581994.5247. | 1,905,674 | 직접(D) | 예 | F1, F2 - F1 Represents a sale pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on June 15, 2026 (the 10b5-1 Plan). The 10b5-1 Plan is scheduled to terminate on June 15, 2027 and covers the sale of up to an aggregate of 500,000 shares of the Issuer's common stock. Trading under the 10b5-1 Plan did not commence until at least 90 days following the date on which the plan was entered.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.10 to $17.095 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001837336-26-000044 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 10월 1일 2026년 10월 5일 제출 | Neagle Matthew Officer: Chief Operating Officer | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 5,594 | 17.1662 | 96,027.7228 산출: 주식 수 × 주당 가격. 정확한 값 96027.7228. | 1,900,080 | 직접(D) | 예 | F1, F3 - F1 Represents a sale pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on June 15, 2026 (the 10b5-1 Plan). The 10b5-1 Plan is scheduled to terminate on June 15, 2027 and covers the sale of up to an aggregate of 500,000 shares of the Issuer's common stock. Trading under the 10b5-1 Plan did not commence until at least 90 days following the date on which the plan was entered.
- F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.10 to $17.30 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001837336-26-000044 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 9월 14일 2026년 9월 16일 제출 | Neagle Matthew Officer: Chief Operating Officer | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 50,000 | 16.4581 | 822,905 산출: 주식 수 × 주당 가격. 정확한 값 822905.0000. | 1,940,705 | 직접(D) | 예 | F1, F2 - F1 Represents a sale pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on June 15, 2026 (the 10b5-1 Plan). The 10b5-1 Plan is scheduled to terminate on June 15, 2027 and covers the sale of up to an aggregate of 500,000 shares of the Issuer's common stock. Trading under the 10b5-1 Plan did not commence until at least 90 days following the date on which the plan was entered.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.05 to $17.0499 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001837336-26-000039 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 9월 14일 2026년 9월 16일 제출 | Reierson Amanda L Director | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 33,135 | 16.4573 | 545,312.6355 산출: 주식 수 × 주당 가격. 정확한 값 545312.6355. | 134,180 | 직접(D) | 예 | F1, F2 - F1 Represents a sale pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on June 15, 2026 (the 10b5-1 Plan). The 10b5-1 Plan is scheduled to terminate on June 18, 2027, and covers the sale of up to an aggregate of 54,054 shares of the Issuer's common stock to help satisfy tax obligations upon the vesting of shares received for service on the Company's board of directors. Trading under the 10b5-1 Plan did not commence until at least 90 days following the date on which the plan was entered.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.08 to $16.79 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001950180-26-000004 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 8월 5일 2026년 8월 7일 제출 | Tabak Shawn Officer: CHIEF FINANCIAL OFFICER | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 25,000 | 16.2063 | 405,157.5 산출: 주식 수 × 주당 가격. 정확한 값 405157.5000. | 215,495 | 직접(D) | 예 | F1, F2 - F1 Represents a sale pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on November 19, 2025 (the 10b5-1 Plan). The 10b5-1 Plan is scheduled to terminate on March 31, 2027, and covers the sale of up to an aggregate of 140,000 shares of the Issuer's common stock. The remaining shares covered by the 10b5-1 plan are at a limit price that exceeds the most recent Nasdaq closing price. Trading under the 10b5-1 Plan did not commence until at least 90 days following the date on which the plan was entered. This sale was effected in connection with tax planning, and the proceeds from the transaction are being used to help satisfy tax obligations of the Reporting Person.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.025 to $16.540 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001954327-26-000046 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 7월 2일 2026년 7월 7일 제출 | Tabak Shawn Officer: CHIEF FINANCIAL OFFICER | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 25,000 | 16.1311 | 403,277.5 산출: 주식 수 × 주당 가격. 정확한 값 403277.5000. | 240,495 | 직접(D) | 예 | F1, F2 - F1 Represents a sale pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on November 19, 2025 (the 10b5-1 Plan). The 10b5-1 Plan is scheduled to terminate on March 31, 2027, and covers the sale of up to an aggregate of 140,000 shares of the Issuer's common stock. Trading under the 10b5-1 Plan did not commence until at least 90 days following the date on which the plan was entered. This sale was effected in connection with tax planning, and the proceeds from the transaction are being used to help satisfy tax obligations of the Reporting Person.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.31 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001954327-26-000043 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 6월 10일 2026년 6월 12일 제출 | Reierson Amanda L Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | 취득(A) | 15,940 | 0 | — | 167,315 | 직접(D) | 아니요 | F1 - F1 Represents an annual grant of restricted stock units (RSUs) for service on the Porch Group, Inc. (the Company) board of directors under the Company's Non-Employee Director Compensation Policy. Each RSU represents a right to receive one share of Company common stock upon vesting. The shares underlying the RSUs will vest on the one-year anniversary of the grant date (Annual Grant Vesting Date), subject to the reporting person remaining a
member of the Company's board of directors through the Annual Grant Vesting Date. The shares underlying the RSUs shall have resale restrictions pursuant to which two-thirds of the vested shares underlying the RSUs may not be sold after the Annual Grant Vesting Date. The resale restrictions expire in equal increments on the first and second anniversaries of the Annual Grant Vesting Date.
| 제출 문서 열기 0001950180-26-000002 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 6월 10일 2026년 6월 12일 제출 | Kell Sean Davis Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | 취득(A) | 15,940 | 0 | — | 313,647 | 직접(D) | 아니요 | F1 - F1 Represents an annual grant of restricted stock units (RSUs) for service on the Porch Group, Inc. (the Company) board of directors under the Company's Non-Employee Director Compensation Policy. Each RSU represents a right to receive one share of Company common stock upon vesting. The shares underlying the RSUs will vest on the one-year anniversary of the grant date (Annual Grant Vesting Date), subject to the reporting person remaining a
member of the Company's board of directors through the Annual Grant Vesting Date. The shares underlying the RSUs shall have resale restrictions pursuant to which two-thirds of the vested shares underlying the RSUs may not be sold after the Annual Grant Vesting Date. The resale restrictions expire in equal increments on the first and second anniversaries of the Annual Grant Vesting Date.
| 제출 문서 열기 0001916515-26-000002 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 6월 10일 2026년 6월 12일 제출 | Velasquez Camilla Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | 취득(A) | 15,940 | 0 | — | 219,291 | 직접(D) | 아니요 | F1 - F1 Represents an annual grant of restricted stock units (RSUs) for service on the Porch Group, Inc. (the Company) board of directors under the Company's Non-Employee Director Compensation Policy. Each RSU represents a right to receive one share of Company common stock upon vesting. The shares underlying the RSUs will vest on the one-year anniversary of the grant date (Annual Grant Vesting Date), subject to the reporting person remaining a
member of the Company's board of directors through the Annual Grant Vesting Date. The shares underlying the RSUs shall have resale restrictions pursuant to which two-thirds of the vested shares underlying the RSUs may not be sold after the Annual Grant Vesting Date. The resale restrictions expire in equal increments on the first and second anniversaries of the Annual Grant Vesting Date.
| 제출 문서 열기 0001904232-26-000002 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 6월 10일 2026년 6월 12일 제출 | Lam Rachel Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | 취득(A) | 15,940 | 0 | — | 193,931 | 직접(D) | 아니요 | F1 - F1 Represents an annual grant of restricted stock units (RSUs) for service on the Porch Group, Inc. (the Company) board of directors under the Company's Non-Employee Director Compensation Policy. Each RSU represents a right to receive one share of Company common stock upon vesting. The shares underlying the RSUs will vest on the one-year anniversary of the grant date (Annual Grant Vesting Date), subject to the reporting person remaining a
member of the Company's board of directors through the Annual Grant Vesting Date. The shares underlying the RSUs shall have resale restrictions pursuant to which two-thirds of the vested shares underlying the RSUs may not be sold after the Annual Grant Vesting Date. The resale restrictions expire in equal increments on the first and second anniversaries of the Annual Grant Vesting Date.
| 제출 문서 열기 0001579232-26-000002 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 6월 10일 2026년 6월 12일 제출 | Vengalil Regi Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | 취득(A) | 15,940 | 0 | — | 181,843 | 직접(D) | 아니요 | F1 - F1 Represents an annual grant of restricted stock units (RSUs) for service on the Porch Group, Inc. (the Company) board of directors under the Company's Non-Employee Director Compensation Policy. Each RSU represents a right to receive one share of Company common stock upon vesting. The shares underlying the RSUs will vest on the one-year anniversary of the grant date (Annual Grant Vesting Date), subject to the reporting person remaining a
member of the Company's board of directors through the Annual Grant Vesting Date. The shares underlying the RSUs shall have resale restrictions pursuant to which two-thirds of the vested shares underlying the RSUs may not be sold after the Annual Grant Vesting Date. The resale restrictions expire in equal increments on the first and second anniversaries of the Annual Grant Vesting Date.
| 제출 문서 열기 0001837531-26-000002 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 6월 10일 2026년 6월 12일 제출 | Pickerill Alan R Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | 취득(A) | 15,940 | 0 | — | 198,356 | 직접(D) | 아니요 | F1 - F1 Represents an annual grant of restricted stock units (RSUs) for service on the Porch Group, Inc. (the Company) board of directors under the Company's Non-Employee Director Compensation Policy. Each RSU represents a right to receive one share of Company common stock upon vesting. The shares underlying the RSUs will vest on the one-year anniversary of the grant date (Annual Grant Vesting Date), subject to the reporting person remaining a
member of the Company's board of directors through the Annual Grant Vesting Date. The shares underlying the RSUs shall have resale restrictions pursuant to which two-thirds of the vested shares underlying the RSUs may not be sold after the Annual Grant Vesting Date. The resale restrictions expire in equal increments on the first and second anniversaries of the Annual Grant Vesting Date.
| 제출 문서 열기 0001716426-26-000002 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 6월 10일 2026년 6월 12일 제출 | TULLOCH MAURICE Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | 취득(A) | 15,940 | 0 | — | 141,706 | 직접(D) | 아니요 | F1 - F1 Represents an annual grant of restricted stock units (RSUs) for service on the Porch Group, Inc. (the Company) board of directors under the Company's Non-Employee Director Compensation Policy. Each RSU represents a right to receive one share of Company common stock upon vesting. The shares underlying the RSUs will vest on the one-year anniversary of the grant date (Annual Grant Vesting Date), subject to the reporting person remaining a
member of the Company's board of directors through the Annual Grant Vesting Date. The shares underlying the RSUs shall have resale restrictions pursuant to which two-thirds of the vested shares underlying the RSUs may not be sold after the Annual Grant Vesting Date. The resale restrictions expire in equal increments on the first and second anniversaries of the Annual Grant Vesting Date.
| 제출 문서 열기 0001877426-26-000002 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 6월 2일 2026년 6월 4일 제출 | Tabak Shawn Officer: CHIEF FINANCIAL OFFICER | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 3,944 | 10.8701 | 42,871.6744 산출: 주식 수 × 주당 가격. 정확한 값 42871.6744. | 265,495 | 직접(D) | 아니요 | F1, F2 - F1 This sale was required by the Issuer at its election (without any discretion by the Reporting Person), and represents shares sold to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units (RSUs) that vested on June 1, 2026. The Issuer has adopted this sell-to-cover method as the sole means for plan participants to satisfy tax withholding obligations in connection with the settlement of awards. The RSUs were granted on December 1, 2025 as part of the fourth and final annual grant of 25% of the Reporting Person's on hire award and will vest in equal installments every six months from the date of the grant.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.8700 to $10.8850 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001954327-26-000041 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 5월 26일 2026년 5월 28일 제출 | Tabak Shawn Officer: CHIEF FINANCIAL OFFICER | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 30,000 | 10.084 | 302,520 산출: 주식 수 × 주당 가격. 정확한 값 302520.000. | 269,439 | 직접(D) | 예 | F1, F2 - F1 Represents a sale pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on November 19, 2025 (the 10b5-1 Plan). The 10b5-1 Plan is scheduled to terminate on March 31, 2027, and covers the sale of up to an aggregate of 140,000 shares of the Issuer's common stock. The remaining shares covered by the 10b5-1 plan are at a limit price that exceeds the most recent Nasdaq closing price. Trading under the 10b5-1 Plan did not commence until at least 90 days following the date on which the plan was entered. This sale was effected in connection with tax planning, and the proceeds from the transaction are being used to help satisfy tax obligations of the Reporting Person.
- F2 The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.70 to $10.37 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001954327-26-000037 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 5월 20일 2026년 5월 21일 제출 | Ehrlichman Matt Director · Officer: CEO, CHAIRMAN AND FOUNDER · 10% owner | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 120,368 | 9.7758 | 1,176,693.4944 산출: 주식 수 × 주당 가격. 정확한 값 1176693.4944. | 15,972,080 | 직접(D) | 아니요 | F1, F2 - F1 This sale was required by the Issuer at its election (without any discretion by the Reporting Person) under a sell-to-cover method as the sole means for plan participants to satisfy tax withholding obligations in connection with the settlement of performance-based restricted stock unit (PRSU) awards that vested on April 7, 2026. As previously disclosed, the Issuer has confirmed its intent to settle vested shares of Common Stock for these PRSU awards in several transactions over approximately 45 days, between April 7, 2026 and May 21, 2026 to reduce market impact.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.61 to $10.08 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001515184-26-000036 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 5월 20일 2026년 5월 21일 제출 | Tabak Shawn Officer: CHIEF FINANCIAL OFFICER | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 10,881 | 9.7758 | 106,370.4798 산출: 주식 수 × 주당 가격. 정확한 값 106370.4798. | 299,439 | 직접(D) | 아니요 | F1, F2 - F1 This sale was required by the Issuer at its election (without any discretion by the Reporting Person) under a sell-to-cover method as the sole means for plan participants to satisfy tax withholding obligations in connection with the settlement of performance-based restricted stock unit (PRSU) awards that vested on April 7, 2026. As previously disclosed, the Issuer has confirmed its intent to settle vested shares of Common Stock for these PRSU awards in several transactions over approximately 45 days, between April 7, 2026 and May 21, 2026 to reduce market impact.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.61 to $10.08 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001954327-26-000034 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 5월 20일 2026년 5월 21일 제출 | Neagle Matthew Officer: Chief Operating Officer | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 62,344 | 9.7758 | 609,462.4752 산출: 주식 수 × 주당 가격. 정확한 값 609462.4752. | 1,990,705 | 직접(D) | 아니요 | F1, F2 - F1 This sale was required by the Issuer at its election (without any discretion by the Reporting Person) under a sell-to-cover method as the sole means for plan participants to satisfy tax withholding obligations in connection with the settlement of performance-based restricted stock unit (PRSU) awards that vested on April 7, 2026. As previously disclosed, the Issuer has confirmed its intent to settle vested shares of Common Stock for these PRSU awards in several transactions over approximately 45 days, between April 7, 2026 and May 21, 2026 to reduce market impact.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.61 to $10.08 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001837336-26-000037 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 5월 15일 2026년 5월 19일 제출 | Neagle Matthew Officer: Chief Operating Officer | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 59,983 | 10.3405 | 620,254.2115 산출: 주식 수 × 주당 가격. 정확한 값 620254.2115. | 2,053,049 | 직접(D) | 아니요 | F1, F2 - F1 This sale was required by the Issuer at its election (without any discretion by the Reporting Person) under a sell-to-cover method as the sole means for plan participants to satisfy tax withholding obligations in connection with the settlement of performance-based restricted stock unit (PRSU) awards that vested on April 7, 2026. As previously disclosed, the Issuer has confirmed its intent to settle vested shares of Common Stock for these PRSU awards in several transactions over approximately 45 days, between April 7, 2026 and May 21, 2026 to reduce market impact.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.02 to $10.79 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001837336-26-000033 제출 문서의 XML에서 읽음 이 행에 이의 제기 |
| 2026년 5월 15일 2026년 5월 19일 제출 | Ehrlichman Matt Director · Officer: CEO, CHAIRMAN AND FOUNDER · 10% owner | S Open market or private sale of non-derivative or derivative security Common Stock | 처분(D) | 115,805 | 10.3405 | 1,197,481.6025 산출: 주식 수 × 주당 가격. 정확한 값 1197481.6025. | 16,092,448 | 직접(D) | 아니요 | F1, F2 - F1 This sale was required by the Issuer at its election (without any discretion by the Reporting Person) under a sell-to-cover method as the sole means for plan participants to satisfy tax withholding obligations in connection with the settlement of performance-based restricted stock unit (PRSU) awards that vested on April 7, 2026. As previously disclosed, the Issuer has confirmed its intent to settle vested shares of Common Stock for these PRSU awards in several transactions over approximately 45 days, between April 7, 2026 and May 21, 2026 to reduce market impact.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.02 to $10.79 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
| 제출 문서 열기 0001515184-26-000034 제출 문서의 XML에서 읽음 이 행에 이의 제기 |